|
|
|
| Analysis of relevant factors of abnormal component factors in metabolic syndrome in pre- and post-menopausal women |
| ZHANG Jingfei1 BAI Wenpei1▲ SHAO Sujun2 ZHANG Tingyue3 DIAO He1 CHEN Xing4 |
1.Department of Obstetrics and Gynecology, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China;
2.Medical Examination Center, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China;
3.Department of Clinical Medicine, Xiangya School of Medicine, Central South University, Hu′nan Province, Changsha 410013, China;
4.Department of Obstetrics and Gynecology, the First Hospital of Peking University, Beijing 100034, China |
|
|
|
Abstract Objective To study the relevant risk factors of metabolic disorders in pre- and post-menopausal women. Methods Eighty-four healthy women aged 45-55 years from 1st to 30th, June 2016 in Beijing Shijitan Hospital, Capital Medical University were chosen as the research object. According to the guidelines of the 2013 Chinese Diabetes Society (CDS) in metabolic syndrome (MS) diagnostic criteria, women were divided into normal metabolic group (n=39) and abnormal metabolic group (n=45). The general condition, reproductive history, past history, lifestyle and menopause symptoms were recorded through questionnaire and physical examination was done. Blood testing was performed, including anti Mullerian hormone (AMH), sex hormone, blood lipid, blood routine, blood biochemistry, etc. Univariate and multiple Logistic regression analysis were used for estimating odds ratios for the association of abnormal component factors in metabolic syndrome and the various factors. Results Univariate analysis showed that history of uterine leiomyoma, sitting time, frequencies of eating fruit, platelet count, platelet volume, platelet distribution width, uric acid, gamma glutamyl transferase and creatinine, the difference was statistically significant between group (P < 0.05). Multivariate Logistic regression showed that history of uterine leiomyoma (OR=9.219; 95%CI: 1.232-68.991; P=0.031) and increase of serum uric acid (OR=1.019; 95%CI: 1.003-1.035; P=0.019) were positively related to abnormal metabolic factors of metabolic syndrome. Conclusion Sedentary behavior, history of uterine leiomyoma and hyperuricemia may be the risk factors of metabolic abnormality in pre-and post-menopausal women. Fruit intake may have protective effect on metabolic syndrome. However, there was no correlation between ovarian function and metabolic syndrome.
|
|
|
|
|
|
[1] 马中书，冯晓路，朱萍.代谢综合征与相关疾病的临床研究进展[J].中国全科医学，2015（17）：1991-1995.
[2] Mottillo S，Filion K B，Genest J，et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis [J]. J Am Coll Cardiol，2010，56（14）：1113-1132.
[3] Agnoli C，Grioni S，Sieri S，et al. Metabolic syndrome and breast cancer risk：a case-cohort study nested in a multicentre italian cohort [J]. PLoS One，2015，10（6）：e0128891.
[4] Trabert B，Wentzensen N，Felix AS，et al. Metabolic Syndrome and risk of endometrial cancer in the United States：a Study in the SEER-Medicare linked database [J]. Cancer Epidemiol Biomarkers Prev，2015，24（1）：261-267.
[5] Esposito K，Chiodini P，Colao A，et al. Metabolic Syndrome and Risk of Cancer： A systematic review and meta-analysis [J]. Diabetes Care，2012，35（11）：2402-2411.
[6] 中华医学会糖尿病学分会.中国2型糖尿病防治指南（2013年版）[J].中华内分泌代谢杂志，2014，30（10）：447-498.
[7] Indhavivadhana S，Rattanachaiyanont M，Wongvananurak T，et al. Predictors for metabolic syndrome in perimenopausal and postmenopausal Thai women [J]. Climacteric，2011（14）：58-65.
[8] Romaguera J，Ortiz AP，Roca FJ，et al. Factors associated with metabolic syndrome in a sample of women in Puerto Rico [J]. Menopause，2010，17（2）：388-392.
[9] Marjani A，Moghasemi S. The metabolic syndrome among postmenopausal women in Gorgan[J]. Int J Endocrinol，2012（2012）：953627.
[10] Pandey S，Srinivas M，Agashe S，et al. Menopause and metabolic syndrome：a study of 498 urban women from western India [J]. J Midlife Health，2010（1）：63-69.
[11] Heidari R，Sadeghi M，Talaei M，et al. Metabolic syndrome in menopausal transition： Isfahan Healthy Heart Program，a population based study[J]. Diabetol Metab Syndr，2010，2（1）：59.
[12] Jouyandeh Z，Nayebzadeh F，Qorbani M，et al. Metabolic syndrome and menopause [J]. J Diabetes Metab Disord，2013，12（1）：1-4.
[13] Figueiredo Neto JA，Figuerêdo ED，Barbosa JB，et al. Metabolic syndrome and menopause：cross-sectional study in gynecology clinic [J]. Arq Bras Cardiol，2010，95（3）：339-345.
[14] 郁琦.绝经学[M].北京：人民卫生出版社，2013：76-78.
[15] Broer SL，Broekmans FJ，Laven JS，et al. Anti-mulleria hormone： ovarian reserve testing and its potential clinical implications [J]. Hum Reprod Update，2014，20（5）：688-701.
[16] Dewailly D，Andersen CY，Balen A，et al. The physiology and clinical utility of anti-Mullerian hormone in women [J]. Hum Reprod Update，2014，20（5）：370-385.
[17] Tak YJ，Sang YL，Sun KP，et al. Association between uterine leiomyoma and metabolic syndrome in parous premenopausal women：A case–control study [J]. Medicine，2016，95（46）：e5325.
[18] 林丹，郑禄城，许晓玲.高尿酸血症与代谢综合征各组分关系的临床研究[J].中国医药导报，2011，8（20）：85-87.
[19] Vigna L，Vassalle C，Tirelli AS，et al. Gender-related association between uric acid，homocysteine，γ-glutamyltransferase，inflammatory biomarkers and metabolic syndrome in subjects affected by obesity [J]. Biomark Med，2017，2017-0072.
[20] Techatraisak K，Kongkaew T. The association of hyperuricemia and metabolic syndrome in Thai postmenopausal women [J]. Climacteric，2017，20（6）：552-557.
[21] 岳松，田凤石.代谢综合征的诊断标准和防治研究进展[J].天津医药，2011，39（8）：770-773. |
|
|
|
